ListarArtículos (Medicina) por materia "2-drug regimen"
Mostrando ítems 1-1 de 1
-
Artículo
Evaluation of Inflammation and Atherogenesis Biomarkers Through 148 Weeks Postswitch to Dolutegravir and Rilpivirine in SWORD-1/SWORD-2
(Lippincott, Williams & Wilkins, 2022-09-01)Background: Switching to the 2-drug regimen dolutegravir + rilpivirine demonstrated noninferiority vs continuing a 3-drug ...